Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
for Hematologic Neoplasms
2 locations incl. Bethesda
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 12 - 85·Accepts healthy volunteers
Code: NCT04959175·Phase 1, Phase 2·Recruiting